San Diego, March 6, 2025 – Coastar Therapeutics Inc., a biotechnology company developing novel delivery technologies to supercharge cell and gene therapies, proudly announces that Nobel Prize Laureate Dr. Randy Schekman has joined its Scientific Advisory Board. A globally recognized leader in cell biology, Dr. Schekman is a Professor at UC Berkeley and an Investigator at the Howard Hughes Medical Institute. His groundbreaking research in vesicular transport and cellular trafficking earned him the 2013 Nobel Prize in Physiology or Medicine, and his expertise will be instrumental in advancing Coastar’s mission to democratize genetic medicine. 

“We are thrilled and honored to welcome Dr. Randy Schekman to our Scientific Advisory Board,” said Eddie Chung, CEO of Coastar Therapeutics. “His visionary work has shaped the foundation of modern cell biology, and his insights will be invaluable as we push the frontiers of genetic medicine. His guidance will undoubtedly accelerate our efforts to develop transformative therapies for patients in need around the world.”

“Dr. Schekman’s pioneering discoveries have profoundly impacted our understanding of cell membrane vesicles traffiking, which aligns perfectly with Coastar’s mission,” said Dr. Han L. Lim, Chief Scientific Officer. “Having his strategic insights as we refine and optimize our gene delivery platform is an incredible advantage. His involvement marks a significant milestone for Coastar.”

“Our technology is at the intersection of cell biology, bioengineering, and therapeutic innovation, and having an esteemed scientist like Professor Schekman on board reinforces the strength of our approach,” said Dr. Chongyang Luo, Chief Operating Officer. “His deep expertise will be key as we translate our discoveries into impactful therapies for patients worldwide.”

Dr. Schekman’s addition to Coastar Therapeutics’ Scientific Advisory Board underscores the company’s commitment to leveraging world-class scientific expertise in its pursuit of breakthrough medical solutions.

For more information about Coastar Therapeutics and its mission, visit coastartherapeutics.com.

ABOUT COASTAR THERAPEUTICS

Coastar Therapeutics Inc., is a San Diego based company developing biological payload delivery technologies for cancer and gene therapies. The company’s proprietary ENHEnS^TM  and eLNPTM technology can coat cell membranes on biological payloads to help them evade recognition and clearance by the immune system and be successfully targeted to tumor or other disease sites. The company is working with a number of global partners to develop next generation therapies.